Hovione appoints Minchom vice president

Wednesday, March 14, 2012 09:14 AM

Dr. Colin Minchom has been appointed as vice president of Hovione’s particle design business unit. He will be based in East Windsor, N.J., and report to Guy Villax, CEO of Hovione.

Minchom brings 29 years of experience in the process, science and global regulation of drug development, with emphasis on dosage forms and drug delivery. Previously, he has served at Patheon as vice president, pharmaceutical development services for North America. Minchom has also held positions at Eli Lilly, Cerebrus, a private U.K. pharmaceutical company, and ER.

He is also chair of the American Association of Pharmaceutical Scientists (AAPS) 2012 Annual Meeting Planning Committee for Chicago and volunteers at the United States Pharmacopoeia (USP) as member of an Expert Committee addressing small molecules.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs